PuriMed announces Phase II clinical trial of lotus seed in depression patients

Published: 2007-10-15 06:57:00

Updated: 2007-10-15 06:57:00

PuriMed, a local biopharmaceutical company, has recently announced the commencement of the Phase II clinical trial in patients with depression using a natural product PM011 (trade name: Lotuzol).

This control, double-blind Phase II clinical trial, which has been accepted by the Korea Food and ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK